These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2134866)

  • 1. Structure of heparan sulfate from rat kidney and liver.
    Kamada A; Kawamura M; Nakamichi K; Sakaki T
    Shika Kiso Igakkai Zasshi; 1990 Feb; 32(1):80-2. PubMed ID: 2134866
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of streptozotocin-induced diabetes on the structure of heparan sulfate from rat kidneys.
    Kamada A
    J Osaka Dent Univ; 1989 Oct; 23(2):63-75. PubMed ID: 2534890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel heparan sulfate proteoglycan found in the extracellular matrix of liver sinusoids and basement membranes.
    Soroka CJ; Farquhar MG
    J Cell Biol; 1991 Jun; 113(5):1231-41. PubMed ID: 2040650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of human liver heparan sulfate.
    Vongchan P; Warda M; Toyoda H; Toida T; Marks RM; Linhardt RJ
    Biochim Biophys Acta; 2005 Jan; 1721(1-3):1-8. PubMed ID: 15652173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disaccharide composition of heparan sulfates: brain, nervous tissue storage organelles, kidney, and lung.
    Tekotte H; Engel M; Margolis RU; Margolis RK
    J Neurochem; 1994 Mar; 62(3):1126-30. PubMed ID: 8113800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of 2-O-sulphated D-glucuronic acid in rat liver heparan sulphate.
    Kovensky J; Cirelli AF
    Carbohydr Res; 1993 Jul; 245(2):361-5. PubMed ID: 8370032
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats.
    Kjellén L; Bielefeld D; Hook M
    Diabetes; 1983 Apr; 32(4):337-42. PubMed ID: 6219905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.
    Lyon M; Gallagher JT
    Biochem J; 1991 Jan; 273(Pt 2)(Pt 2):415-22. PubMed ID: 1846741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric methods for the analysis of heparin and heparan sulfate.
    Lech M; Capila I; Kaundinya GV
    Methods Mol Biol; 2015; 1229():119-28. PubMed ID: 25325949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New electrophoretic and chromatographic techniques for analysis of heparin and heparan sulfate.
    Viola M; Vigetti D; Karousou E; Bartolini B; Genasetti A; Rizzi M; Clerici M; Pallotti F; De Luca G; Passi A
    Electrophoresis; 2008 Aug; 29(15):3168-74. PubMed ID: 18633938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Function and structure of heparan sulfate-modification of FGF activities].
    Ishihara M
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(9):1122-33. PubMed ID: 7667499
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of heparan sulphate proteoglycans from bovine glomerular basement membranes with those from whole cortex.
    Dossett RF; Anderson JC
    Biochem Soc Trans; 1990 Oct; 18(5):959. PubMed ID: 2083766
    [No Abstract]   [Full Text] [Related]  

  • 13. Lead-induced alteration of heparan sulfate proteoglycans in cultured vascular endothelial cells.
    Kaji T; Ohkawara S; Nakajima M; Yamamoto C; Fujiwara Y; Miyajima S; Koizumi F
    Toxicology; 1997 Mar; 118(1):1-10. PubMed ID: 9074649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and partial characterization of heparan sulphate proteoglycans from human hepatic amyloid.
    Magnus JH; Stenstad T; Husby G; Kolset SO
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):225-31. PubMed ID: 1445267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 alters glomerular heparan sulfate glycosaminoglycan chain size and charge in rats.
    Garin EH; West L; Zheng W
    Pediatr Nephrol; 2000 Apr; 14(4):284-7. PubMed ID: 10775070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and pathology of the pericellular heparan sulphate proteoglycans.
    David G
    Biochem Soc Trans; 1991 Nov; 19(4):816-20. PubMed ID: 1794564
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.
    Nakanishi H; Oguri K; Yoshida K; Itano N; Takenaga K; Kazama T; Yoshida A; Okayama M
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture synthesis and "charge tagging" based demixing: an efficient strategy for the preparation of heparan sulfate libraries.
    Dilhas A; Lucas R; Loureiro-Morais L; Hersant Y; Bonnaffé D
    J Comb Chem; 2008; 10(2):166-9. PubMed ID: 18278875
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological significance of heparan sulfate proteoglycans.
    Buonassisi V; Colburn P
    Ann N Y Acad Sci; 1982; 401():76-84. PubMed ID: 6220631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Structure of heparin/heparan sulfate for regulation of activities of fibroblast growth factor].
    Ishihara M
    Seikagaku; 1998 Feb; 70(2):96-100. PubMed ID: 9549408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.